Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Dow
Fish and Richardson
Chinese Patent Office
Fuji
QuintilesIMS
Johnson and Johnson
Healthtrust
Boehringer Ingelheim

Generated: February 16, 2019

DrugPatentWatch Database Preview

Sulfacetamide sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sulfacetamide sodium and what is the scope of sulfacetamide sodium freedom to operate?

Sulfacetamide sodium is the generic ingredient in seventeen branded drugs marketed by Valeant Pharms North, Fougera Pharms, Perrigo Co Tennessee, Taro, Allergan, Alcon, Schering, Pharmafair, Miza Pharms Usa, Akorn, Sola Barnes Hind, Novartis, Optopics, Alcon Pharms Ltd, Bausch And Lomb, and Sandoz Inc, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sulfacetamide sodium. Twenty-one suppliers are listed for this compound.

Pharmacology for sulfacetamide sodium
Medical Subject Heading (MeSH) Categories for sulfacetamide sodium
Synonyms for sulfacetamide sodium
127-56-0
144-80-9 (Parent)
30760ZE777
AB00513796
AC-7629
AC1N2JI9
Acetamide, N-((4-aminophenyl)sulfonyl)-, sodium salt (1:1)
ACETAMIDE, N-SULFANILYL-, MONOSODIUM SALT
Acetamide, N-sulfanilyl-, N-sodium deriv
Acetamide, N-sulfanilyl-, sodium deriv
AKOS003281404
AKOS025402286
Albucid soluble
Albucid-Natrium
Albucide
Almocetamide
AN-23002
Antebor
API0004257
AS-13361
Beocid-isoptal
Blefamide
Bleph 10
C08051
Cetamide
CHEBI:9327
CHEMBL1200416
EINECS 204-848-4
Farmamid
FT-0631741
Galseptil
H994
HMS3652G10
J-005502
KS-0000129C
Locula
LT03330165
LT03381141
MFCD00007885
MFCD00149555
Minims sulphacetamide
MolPort-001-520-453
N-((4-Aminophenyl)sulfonyl)-acetamide monosodium salt
N-(4-Aminophenylsulfonyl)acetamide sodium salt
N-[(4-aminophenyl)sulfonyl]acetamide, sodium salt
N-Acetyl-4-aminobenzenesulfonamide Sodium Salt
N-Acetylsulfanilamide Sodium Salt
N-Sulfanilylacetamide sodium
N-Sulfanilylacetamide sodium salt
N-Sulfanilylacetamide, sodium salt
N(1)-acetylsulfanilamide sodium
N(1)-acetylsulfanilamide sodium salt
N(sup 1)-Acetylsulfanilamide sodium
N(sup 1)-Acetylsulfanilamide sodium salt
N1-Acetylsulfanilamide sodium
N1-Acetylsulfanilamide sodium salt
Oc-U-Mid
Octsetan
Opulets sulpjacetamide
OR011665
OR211673
PQMSFAORUFMASU-UHFFFAOYSA-M
Prontamid
S0578
s4081
SCHEMBL3051698
Sebizon lotion
Sodium Acetyl-(4-aminophenyl)sulfonyl-azanide
sodium acetyl-(4-aminophenyl)sulfonylazanide
Sodium acetyl((4-aminophenyl)sulfonyl)amide
sodium acetyl[(4-aminophenyl)sulfonyl]azanide
Sodium albucid
Sodium N-sulfanilylacetamide
Sodium sulfacetamide
SODIUM SULFACETAMIDE(1-)
Sodium sulfacyl
Sodium sulfanilylacetamide
Sodium, N(sup 1)-acetylsulfanilamido-
Soluble sulfacetamide
Soluble sulfacyl
ST50407307
Sulamyd sodium
Sulf 10
Sulf-10 Ophthalmic
Sulfableph
Sulfacetamid natrium
Sulfacetamide (Sodium)
Sulfacetamide sodium anhydrous
Sulfacetamide sodium salt
Sulfacetamide sodium salt hydrate
Sulfacetamide Sodium, pharmaceutical secondary standard; traceable to USP, PhEur
Sulfacetamide, sodium
Sulfacetamide, sodium salt
SulfacetamideSodiumSaltHydrate
Sulfacetamidum natricum
Sulfacyl sodium
Sulfacyl sodium salt
Sulfacyl sol
Sulfacyl soluble
Sulphacetamide sodium
UNII-30760ZE777

US Patents and Regulatory Information for sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering SODIUM SULAMYD sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 005963-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alcon CETAMIDE sulfacetamide sodium OINTMENT;OPHTHALMIC 080021-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 077015-001 Nov 17, 2006 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan BLEPH-30 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080028-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Miza Pharms Usa OCUSULF-30 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080660-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn SODIUM SULFACETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 083021-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Queensland Health
Deloitte
AstraZeneca
McKinsey
McKesson
Chinese Patent Office
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.